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Abstract
Background: Noise-induced hearing loss (NIHL) is one of the most common occupational injuries in the United States. 
It would be extremely valuable if a safe, inexpensive compound could be identified which protects worker hearing 
from noise. In a series of experiments, Kopke has shown that the compound N-acetyl-L-cysteine (L-NAC) can protect 
the hearing of chinchillas from the effects of a single exposure to noise. L-NAC is used in clinical medicine and is very 
safe. Although L-NAC was reported to be promising, it has not been successful in other studies (Kramer et al., 2006; 
Hamernik et al., 2008). The present study was undertaken to determine if L-NAC could protect C57BL/6J (B6) mice from 
the permanent effects of noise.
Method: Two groups of five B6 mice were injected with either 300 or 600 mg/kg L-NAC approximately 1 hr prior to a 
104 dB broadband noise exposure and again immediately after the exposure. A control group (N = 7) was exposed to 
the same noise level but injected with vehicle (sterile saline). Auditory brainstem response measurements were made 
at 4, 8, 16 and 32 kHz one week prior to and 12 days after exposure.
Conclusions: There were no statistically significant differences in ABR threshold shifts between the mice receiving L-
NAC and the control mice. This indicates that L-NAC was not effective in preventing permanent threshold shift in this 
mouse model of NIHL.
Background
The inbred mouse strain C57BL/6J (B6) has been shown
to be more susceptible to noise-induced hearing loss
(NIHL) than the CBA/CaJ strain [1]. This phenotype has
been traced to a mutation of the gene coding for cadherin
23, Cdh23 [2].
Staecker et al. [3] demonstrated that the antioxidant
systems of B6 mice have a number of differences when
compared with normal-hearing strains (i.e. CBA/CaJ and
a congenic B6 strain (B6.CAST+ahl mouse) with the Ahl
allele replaced with the wild-type Castaneous  strain
allele). Using immunohistochemical techniques they
showed that qualitative levels of super-oxide dismutase,
glutamyl transferase and 4-hydroxynonenal increase
between 3 month old and 9 month old B6 mice; and differ
from the levels detected in age-matched, normal hearing
CBA/CaJ mice. Using semi-quanitative PCR analyses,
levels of messenger RNA for copper/zinc and magnesium
super-oxide dismutase and catalase B6 mice were statisti-
cally greater than levels expressed in 3 month old CBA/
CaJ mice. On the other hand, the level of glutathione per-
oxidase did not differ statistically in the two strains.
Based on Staecker's results one could argue that the oxi-
dative stress system of a B6 mouse ear is not impaired by
the Cdh23 mutation and in some cases may be enhanced.
This contradicts evidence that B6 ears are more sensitive
to noise-induced hearing loss [4].
One possible prophylactic agent against noise could be
N-acetyl L-cysteine (L-NAC). L-NAC is extremely safe
and has been used for many years to protect the liver
from the toxic effects of acetaminophen overdose. L-
NAC interacts directly with free radicals to prevent liver
damage.
L-NAC (at 325 mg/kg) has been shown in chinchillas to
protect the cochlea from the damaging effects of noise
when combined with salicylate (at 50 mg/kg) and injected
prior to noise exposure [5]. In chinchillas Bielefeld et al.
[6] demonstrated protection by L-NAC to high kurtosis
stimuli (at 325 mg/kg i.p.); protection at doses as low as
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50 mg/kg (i.p.); and protection when given by oral gavage
(325 mg/kg.) In contrast, a more recent study using L-
NAC alone (325 mg/kg) did not detect functional or ana-
tomical protection of the chinchilla inner ear to high kur-
tosis stimuli [7]. While it is possible that this outcome
was related to the impulse noise insult selected for that
study, Duan et al. [8] found dose-dependant protection of
the inner ear in rats exposed to impulse noise. The best
protection was obtained using a three times per day dose
(350 mg/kg/injection). Animals that received only 1 injec-
tion per day, or 5 injections per day, received less benefit.
Kopke and collegues' double-blind, placebo controlled
study of protective effects of oral L-NAC in U.S. Marines
prior to firearms training is of gr ea t in t er est [9]. T hey
report "a favorable biological response" on hearing in
marines treated with L-NAC prior to small arms fire.
There have been three pathways proposed for the
action for L-NAC. First, L-NAC is a precursor for gluta-
thione, the body's natural reactive oxygen species (ROS)
scavenger. Presumably, infusion of L-NAC increases the
cochlea's store of glutathione. It has been shown in brain
that glutathione is actively transported across the blood
brain barrier by a saturable system while L-NAC is trans-
ported by a more general amino acid system. Presumably
the same transporter systems are present in the cochlea
[10]. Second, L-NAC has been shown to have basic pro-
tective properties independent of glutathione: both L-
and D-isomers of NAC were able to protect cells in vitro
from ROS. Since only the L isomer of NAC is enzymati-
cally converted to glutathione, this strongly suggests that
the protective effects of NAC can be independent of glu-
tathione, probably through cell cycle regulation [11].
Third, in cell culture, L-NAC has been shown to block
apoptosis probably through inducing specific gene
expression [12].
Our hypothesis is that the administration of L-NAC
should provide protection against noise sensitivity in B6
mice by boosting the free-radical scavenging mechanisms
of the cochlea. Two dosages were chosen: one which has
been shown to be protective in chinchillas and a second
dose double the first. A protective effect should be evi-
dent.
Materials and methods
All animal procedures were approved by the University of
Cincinnati Institute Animal Care and Use Committee.
Eighteen, four-week old female mice of the C57BL/6J
strain were purchased from The Jackson Lab (TJL), Bar
Harbor, ME. The mice were divided into three groups.
The low dose group received an i.p. injection of 300 mg/
kg of L-NAC (Sigma-Aldrich, Inc. #A7250, CAS 616-91-
1) dissolved in sterile saline one hour before and immedi-
ately after noise exposure (N = 6). The high dose group
received an i.p. injection of 600 mg/kg of L-NAC in sterile
saline, adjusted to pH 7.0 by addition of sodium hydrox-
ide, one hour before and immediately after noise expo-
sure (N = 5). The pH was adjusted after high mortality
was noted in an earlier high dose group. The control
group received an equal volume of sterile saline one hour
before and immediately after noise exposure (N = 7).
Auditory Brainstem Response. Mice were allowed to
accommodate to the facility for one week. All mice were
tested for the ability to generate the auditory brainstem
r e s p o n s e  ( A B R )  i n  w e e k  t w o .  M i c e  w e r e  a n e s t h e t i z e d
with an i.p. injection of Avertin (tribromoethanol, 0.4 mg/
g). Twelve days after exposure mice were ABR tested for a
second time.
Auditory brainstem responses (ABR) were generated to
4, 8, 16 and 32 kHz tone pips (tested in ascending order).
Tone pips consisted of a three millisecond envelope: 1 ms
ramp onset, 1 ms plateau and 1 ms decay. Tone pips were
generated by Tucker-Davis Technologies System 2 hard-
ware (Alachua, FL, USA) running BioSig® Software on a
Pentium class computer. The tone burst was presented
binaurally through specula attached to supertweeters.
The ABR was recorded through Grass® stainless steel nee-
dle electrodes placed subcutaneously at the vertex
(active), right cheek (inverting) and left cheek (common).
The resulting signal was band-pass filtered (100-3000
Hz), amplified (10,000×) and digitized by a TDT Bioamp.
Responses were collected and averaged at 30 presenta-
tions per second for up to 512 times. The stimulus was
presented at 100 dB SPL and progressed downward in 5
dB steps until no response was identifiable. Presentations
were halted early if the characteristic ABR was noted. A
second trace was collected and compared with the first if
there was some question if a response was recorded.
Tone bursts were calibrated by extending the tone burst
plateau to one minute and measuring the output of the
speakers via an 1/8" Brüel & Kjær (B&K) microphone and
a Brüel & Kjær 2608 Measuring Amplifier. A short piece
of polyethylene tubing was connected between the specu-
lum of the supertweeter and the 1/8" microphone, similar
to the technique described by Pearce et al. [13]. The
microphone was calibrated by a B&K microphone cali-
brator.
Noise exposure. Mice were placed in a multi-compart-
ment mesh cage for simultaneous exposure. Mice were
exposed in the third week for one hour to a 104 dB SPL
broadband noise (spectrum was published in Erway et al,
1996)[4]. This level was chosen to produce a measurable
threshold shift in B6 mice but not a total hearing loss [1].
The exposure conditions were continuously monitored
by a 1/4" microphone attached to a Brüel & Kjær 2608
Measuring Amplifier.
Statistical Methods. Analysis of variance (ANOVA) was
used to test for differences in ABR thresholds between
the three groups pre-exposure and post-exposure as wellDavis et al. Journal of Occupational Medicine and Toxicology 2010, 5:11
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as threshold shift due to exposure. A separate model was
used for each frequency. Pairwise contrasts were done if
an effect in an exposure group was statistically significant
(p < 0.05). All calculations were done with SAS (Version
9.2, SAS Institute, Cary, NC).
Results
The analysis of variance found no statistically significant
protective effect for L-NAC. A protective effect would be
demonstrated by a decrease in threshold shift with
increasing L-NAC dose (0, 300 mg/kg, 600 mg/kg). This
was not seen (Figure 1c). Post-exposure ABR thresholds
did not differ in the three groups (Figure 1b; 4 kHz, F =
0.58, p = 0.57; 8 kHz, F = 1.11, p = 0.36; 16 kHz, F = 0.24,
p = 0.79; 32 kHz, F = 2.13, p = 0.15).
At 32 kHz, prior to noise exposure the 600 mg/kg group
mean was statistically significantly better than the two
other group means. We determined that this was proba-
bly due to two mice who had stellar ABR thresholds at 32
kHz--5 to 10 dB better than their peers. (The pre-expo-
sure mean thresholds were: control group 56.1 dB, the
low dose group was 56.7 dB and the high dose group was
40.5 dB). The high dose group mean ABR thresholds after
exposure were about the same as the rest of the groups
(88.5 dB vs 83.2 dB for the control and 76.6 dB for the low
dose group) but it also affected threshold shift for that
frequency. The mean threshold shift at 32 kHz for the
high dose group (48 dB) was greater than for the control
(27.1 dB) or low dose group (20 dB).
Discussion
The present data demonstrate that L-NAC does not pro-
tect B6 mouse hearing from moderate noise exposure.
Ou r  p r ed i ct i o n  t h a t  a n  R O S  s ca v e n g e r ,  L - NA C,  w o u l d
protect the hearing of the mice was not upheld.
We believe that the failure to protect the C57BL/6J
mice may be related to one of the following: Dose level, a
non-ROS mechanism of B6 noise-induced hearing loss,
or a species specific lack of effect by L-NAC. These
hypotheses provide directions for further research.
First, the dosage levels of 300 mg/kg and 600 mg/kg
were chosen based on previous studies in chinchillas
showing a dose of 325 mg/kg as protective against NIHL.
We chose dosages that should be within the protective
range. Generally, dosages must be adjusted up in smaller
animals to obtain equivalent effect. It is possible that in
the mouse an even higher dose of L-NAC might be neces-
sary for otoprotection but we saw no evidence of any pro-
tection in the present study. Bliefield et al. [6]
demonstrated some protection in chinchillas even at 50
mg/kg. Even if the mouse required a dose a magnitude
larger than the chinchilla, a 600 mg/kg dose would meet
that criterion.
Second, it is possible that ROS damage is secondary to
the stereocillia defect in affecting noise-induced hearing
loss in these mice. More likely, however, is that B6 mice
have weakened hair cells due to the abnormal Cdh23
defect. Cadherin 23 is believed to make up part of the ste-
reocillia tip-links. The dysfunctional hair cells in this
strain make them particularly vulnerable to environmen-
tal insults or age-related hearing loss. We argue that B6
Figure 1 Mean Auditory Brainstem Response (ABR) thresholds in 
decibels (dB) for 4, 8, 16 and 32 kHz for C57BL/6J mice. (A) Pre-ex-
posure ABR thresholds. (B) Twelve day post-exposure thresholds. (C) 
Threshold shifts, post-threshold minus pre-threshold. Error bars indi-
cate ± 1 standard deviation.Davis et al. Journal of Occupational Medicine and Toxicology 2010, 5:11
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are an excellent model for NIHL, especially modeling of
susceptible individuals.
Moreover, Staecker et al. [3] have shown production of
endogenous antioxidants in the B6 inner ear. They com-
pared age-matched B6 with normal hearing CBA/CaJ
mice and noted increased labeling for super-oxide dis-
mutase, glutamyl transferase and 4-hydroxynonenal in
the lateral wall and spiral ganglia of B6 mice, which varied
with age between 3 and 9 months of age. Expression lev-
els of antioxidant enzyme mRNA were also elevated, with
peak expression varying with age. Levels of messenger
RNA for copper/zinc and magnesium super-oxide dis-
mutase increased gradually up to 9 months of age, and
were greater than levels expressed in 3 or 9 month old
CBA/CaJ mice. Catalase expression peaked at 6 months
of age in the B6 mice, but was much higher at 9 months of
age in the CBA/CaJ group. On the other hand, the level of
glutathione peroxidase did not differ statistically from the
CBA/CaJ baseline. The time course of these changes par-
allels the hearing threshold shifts and cochlear degenera-
tion which begin at 3-6 months of age. Although cochlear
degeneration and hearing loss in B6 mice was originally
attributed to the Ahl  locus harboring the cadherin 23
mutation, the picture is now more complicated.
Finally, it is possible that mice may not be protected by
L-NAC. First, L-NAC showed no protection again age-
related hearing loss in mice [14]. Blakley et al. [15]
reviewed differences between species highlighting the
differences in ototoxic dose for gentamicin and cisplatin
between mice and guinea pigs. Le Prell et al. [16] demon-
strated that a vitamin and mineral antioxidant regime
protected CBA/J mice from NIHL. Pharmacokinetic
measurements of L-NAC and/or glutathione in mouse
cochlear perilymph and tissue would be very useful but
technically challenging to accomplish.
Two recent studies have shown no otoprotective effect
for L-NAC. Kramer et al. [17] showed that L-NAC did
not protect young adults from temporary threshold shift
while attending a disco venue. Hamernik et al. [7] demon-
strated that L-NAC did not protect the hearing of chin-
chillas when used in conjunction with high kurtosis
impulse noise.
A safe, inexpensive, oral compound which displays pro-
phylactic protection against noise in humans would be
welcomed. Current efforts are underway to study otopro-
tectant antioxidants in human cohorts. Le Prell et al.[18]
have identified a mix of vitamins and minerals effective at
preventing NIHL in guinea pigs. Their mixture is cur-
rently undergoing human clinical trials to determine
effectiveness. Campbell et al. [19] have investigated the
use of D-methionine as an otoprotectant against both
noise and ototoxic drugs. They, too, are clinically testing
their compound on human populations. Ebselin has been
identified as an otoprotectant in animal models [20] and
is undergoing human trials. A quick search of the litera-
ture databases identify a number of compounds which
have been implicated for otoprotection but have not been
further developed.
A compound which protects hearing against both aging
and noise damage would be doubly welcome. Although
research is active, presently there are no compounds
identified which meet these needs. Currently, the effec-
tive use of hearing protection devices appears to be the
best defense against noise-induced hearing loss.
Conclusions
Our data demonstrate that L-NAC does not protect B6
mouse hearing from moderate noise exposure. Our pre-
diction that an ROS scavenger, L-NAC, would protect the
hearing of the mice was not upheld. We conclude that it is
premature to recommend that ROS scavengers be substi-
tuted for noise reduction or hearing protection for pro-
tecting worker's hearing.
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